Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-28 4:38 pm Purchase | 2024-02-23 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | Millennium Management LLC | 544,276 5.300% | 544,276![]() (New Position) | Filing History |
| 2024-02-14 4:45 pm Purchase | 2023-12-31 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | K2 HealthVentures Equity Trust LLC | 342,113 7.500% | 342,113![]() (New Position) | Filing History |
| 2024-02-14 4:41 pm Purchase | 2022-10-25 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | K2 HealthVentures Equity Trust LLC | 10,524,401 7.800% | 10,524,401![]() (New Position) | Filing History |
| 2024-02-14 4:08 pm Sale | 2024-01-26 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | Paradigm BioCapital Advisors LP | 0 0.000% | -399,658![]() (Position Closed) | Filing History |
| 2024-02-12 4:42 pm Purchase | 2024-02-02 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | ADAGE CAPITAL PARTNERS GP L.L.C. | 796,392 7.700% | 796,392![]() (New Position) | Filing History |
| 2024-02-12 4:18 pm Purchase | 2024-02-02 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | RA Capital Management, L.P. | 430,182 4.100% | 430,182![]() (New Position) | Filing History |
| 2024-02-09 4:11 pm Purchase | 2024-01-31 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | Integrated Core Strategies (US) LLC | 419,707 4.100% | 419,707![]() (New Position) | Filing History |
| 2024-02-05 4:47 pm Purchase | 2024-01-26 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | Cormorant Global Healthcare Master Fund LP | 1,475,000 14.270% | 1,475,000![]() (New Position) | Filing History |
| 2024-02-05 4:21 pm Purchase | 2024-01-26 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | Paradigm BioCapital Advisors LP | 399,658 9.000% | 399,658![]() (New Position) | Filing History |
| 2024-01-29 4:40 pm Purchase | 2024-01-26 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | Point72 Asset Management, L.P. | 388,676 8.800% | 388,676![]() (New Position) | Filing History |
| 2024-01-26 4:28 pm Purchase | 2024-01-26 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | TANG CAPITAL PARTNERS LP | 426,220 9.600% | 426,220![]() (New Position) | Filing History |
| 2022-08-24 1:59 pm Sale | 2022-08-23 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | ETF MANAGERS GROUP LLC | 206,489 4.950% | -160,015![]() (-43.66%) | Filing History |
| 2022-02-14 3:55 pm Sale | 2022-02-11 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | ETF MANAGERS GROUP LLC | 366,505 8.780% | -108,174![]() (-22.79%) | Filing History |
| 2021-06-01 1:22 pm Purchase | 2021-05-28 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | ETF MANAGERS GROUP LLC | 474,679 11.390% | 252,230![]() (+113.39%) | Filing History |
| 2021-05-11 1:33 pm Purchase | 2021-05-10 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | ETF MANAGERS GROUP LLC | 222,449 5.340% | 22,537![]() (+11.27%) | Filing History |
| 2021-04-09 6:02 pm Purchase | 2021-03-31 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | BlackRock Inc. BLK | 189,122 4.500% | 15,105![]() (+8.68%) | Filing History |
| 2021-03-17 1:07 pm Purchase | 2021-03-16 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | ETF MANAGERS GROUP LLC | 199,911 4.800% | 4,867![]() (+2.50%) | Filing History |
| 2021-02-16 10:52 am Sale | 2021-02-12 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | ETF MANAGERS GROUP LLC | 195,045 6.960% | -64,827![]() (-24.95%) | Filing History |
| 2021-02-12 1:19 pm Sale | 2021-02-11 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | ETF MANAGERS GROUP LLC | 259,872 9.280% | -37,983![]() (-12.75%) | Filing History |

